Assessment of myocardial viability in a porcine model of chronic coronary artery stenosis with dual dose dobutamine magnetic resonance imaging

International Journal of Cardiovascular Imaging

Volumn 19, Issue 1, 2003, Pages 63-72

  Dymarkowski, Steven ^a   Szilard, M ^a   Maes, A ^a   Liu, X S ^a   Huang, Y M ^a   Verbeken, E ^b   Mortelmans, L ^a   Bogaert, J ^a   De Scheerder, I ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

Dobutamine; Heart; Magnetic resonance imaging; Myocardial viability

Indexed keywords

DOBUTAMINE; INOTROPIC AGENT;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CONVALESCENCE; CORONARY ARTERY OBSTRUCTION; DOSE RESPONSE; DRUG EFFECT; DRUG RESPONSE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE COMPLIANCE; HEART MUSCLE NECROSIS; HEART MUSCLE REVASCULARIZATION; HEART PERFUSION; HEART STIMULATION; HISTOPATHOLOGY; MYOCARDIAL HIBERNATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; REPRODUCIBILITY; SWINE;

EID: 0037309311     PISSN: 15695794     EISSN: 18758312     Source Type: Journal    
DOI: 10.1023/A:1021781205016     Document Type: Article

References (42)

1. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989; 117: 211-221.
2. Braunwald E, Rutherford JD. Reversible ischemic left ventricular dysfunction: Evidence for the 'hibernating myocardium'. J Am Coll Cardiol 1986; 8: 1467-1470.
3. Heusch G. Hibernating myocardium. Physiol Rev 1998; 78: 1055-1085.
4. Maes A, Flameng W, Nuyts J, et al. Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings. Circulation 1994; 90: 735-745.
5. Di Carli MF, Maddahi J, Rokhsar S, et al. Long-term survival of patients with coronary artery disease and left ventricular dysfunction: Implications for the role of myocardial viability assessment in management decisions. J Thorac Cardiovasc Surg 1998; 116: 997-1104.
6. Chaudhry FA, Tauke JT, Alessandrini RS, Vardi G, Parker MA, Bonow RO. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 1999; 34: 730-738.
7. Vanoverschelde JL, Wijns W, Borgers M, et al. Chronic myocardial hibernation in humans. From bedside to bench. Circulation 1997; 95: 1961-1971.
8. Gunning MG, Anagnostopoulos C, Knight CJ, et al. Comparison of 201T1, 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium. Circulation 1998; 98: 1869-1874.
9. Baer FM, Voth E, Theissen P, Schneider CA, Schicha H, Sechtem U. Coronary artery disease: Findings with GRE MR imaging and Tc-99m-methoxyisobutyl-isonitrile SPECT during simultaneous dobutamine stress. Radiology 1994; 193: 203-209.
10. Baer FM, Voth E, Schneider CA, Theissen P, Schicha H, Sechtem U. Comparison of low-dose dobutamine-gradient-echo magnetic resonance imaging and positron emission tomography with. Circulation 1995; 91: 1006-1015.
11. Udelson JE. Steps forward in the assessment of myocardial viability in left ventricular dysfunction. Circulation 1998; 97: 833-838.
12. Martin TW, Seaworth JF, Johns JP, Pupa LE, Condos WR. Comparison of adenosine, dipyridamole, and dobutamine in stress echocardiography. Ann Intern Med 1992; 116: 190-196.
13. Picano E, Mathias W Jr, Pingitore A, Bigi R, Previtali M. Safety and tolerability of dobutamine-atropine stress echocardiography: A prospective, multicentre study. Echo Dobutamine International Cooperative Study Group. Lancet 1994; 344: 1190-1192.
14. Cigarroa CG, DeFilippi CR, Brickner ME, Alvarez LG, Wait MA, Grayburn PA. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 1993; 88: 430-436.
15. Sechtem U, Plugfelder PW, Gould RG. Cassidy MM, Higgins CB. Measurement of right and left ventricular volumes in healthy individuals with cine MR imaging. Radiology 1987; 163: 697-702.
16. Semelka RC, Tomei E, Wagner S, et al. Normal left ventricular dimensions and function: Interstudy reproducibility of measurements with cine MR imaging. Radiology 19990 174: 763-768.
17. Haag UJ, Hess OM, Maier SE, et al. Left ventricular wall thickness measurements by magnetic resonance: A validation study. Int J Card Imaging 1991; 7: 31-41.
18. Schulen V, Schick F, Lichat J. et al. Evaluation of K-space segmented cine sequences for fast functional cardiac imaging. Invest Radiol 1996; 31: 512-522.
19. Foo TK, Bernstein MA, Aisen AM, Hernandez RJ, Collick BD, Berstein T. Improved ejection fraction and flow velocity estimates with use of view sharing and uniform repetition time excitation with fast cardiac techniques. Radiology 1995; 195: 471-478.
20. Nagel E, Lehmkuhl HB, Bocksch W, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: Comparison with dobutamine stress echocardiography. Circulation 1999; 99: 763-770.
21. Nagueh SF, Mikati I, Weilbaecher D, et al. Relation of the contractile reserve of hibernating myocardium to myocardial structure in humans. Circulation 1999; 100: 490-496.
22. Sechtem U, Baer FM, Voth E, Theissen P, Schneider CA. Stress functional MRI: Detection of ischemic heart disease and myocardial viability. J Magn Reson Imaging 1999; 10: 667-675.
23. Chen C, Li L, Chen LL, et al. Incremental doses of dobutamine induce a biphasic response in dysfunctional left ventricular regions subtending coronary stenoses. Circulation 1995; 92: 756-766.
24. Bax JJ, Cornel JH, Visser FC, et al. Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography. J Am Coll Cardiol 1996; 28: 558-564.
25. Hata T, Nohara R, Fujita M, et al. Noninvasive assessment of myocardial viability by positron emission tomography with 11C acetate in patients with old myocardial infarction. Usefulness of low-dose dobutamine infusion. Circulation 1996; 94: 1834-1841.
26. Van Rugge FP, Van Der Wall EE, Spanjersberg SJ, et al. Magnetic resonance imaging during dobutamine stress for detection and localization of coronary artery disease. Quantitative wall motion analysis using a modification of the centerline method. Circulation 1994; 90: 127-138.
27. Van Der Geest RJ, Buller VG, Jansen E, et al. Comparison between manual and semiautomated analysis of left ventricular volume parameters from short-axis MR images. J Comput Assist Tomogr 1997; 21: 756-765.
28. Brenner H, Kliebsch U. Dependence of weighted kappa coefficients on the number of categories. Epidemiology 1996; 7: 199-202.
29. Buda AJ, Zotz RJ, Gallagher KP. The effect of inotropic stimulation on normal and ischemic myocardium after coronary occlusion. Circulation 1987; 76: 163-172.
30. Ruffolo RR Jr. The pharmacology of dobutamine. Am J Med Sci 1987; 294: 244-248.
31. Baer FM, Theissen P, Schneider CA, et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 1998; 31: 1040-1048.
32. Szolar DH, Saeed M, Wendland MF, et al.. MR imaging characterization of postischemic myocardial dysfunction ('stunned myocardium'): Relationship between functional and perfusion abnormalities. J Magn Reson Imaging 1996; 6: 615-624.
33. Gunning MG, Chua TP, Harrington D, et al. Hibernating myocardium: Clinical and functional response to revascularisation. Eur J Cardiothorac Surg 1997; 11: 1105-1112.
34. Van Rugge FP, Van Der Wall EE, De Roos A, Bruschke AV. Dobutamine stress magnetic resonance imaging for detection of coronary artery disease. J Am Coll Cardiol 1993; 22: 431-439.
35. Baer FM, Theissen P, Crnac J, et al. Head to head comparison of dobutamine-transoesophageal echocardiography and dobutamine-magnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery disease. Eur Heart J 2000; 21: 981-991.
36. Van Der Geest RJ, Lelieveldt BP, Reiber JH. Quantification of global and regional ventricular function in cardiac magnetic resonance imaging. Top Magn Reson Imaging 2000; 11; 348-358.
37. Pennell DJ, Underwood SR, Manzara CC, et al. Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am J Cardiol 1992; 70: 34-40.
38. Dendale PA, Franken PR, Waldman GJ, et al. Low-dosage dobutamine magnetic resonance imaging as an alternative to echocardiography in the detection of viable myocardium after acute infarction. Am Heart J 1995; 130: 134-140.
39. Hundley WG, Hamilton CA, Thomas MS, et al. Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 1999; 100: 1697-1702.
40. Gallagher KP, Gerren RA, Ning XH, et al. The functional border zone in conscious dogs. Circulation 1987; 76: 929-942.
41. Homans DC, Asinger R, Elsperger KJ, et al. Regional function and perfusion at the lateral border of ischemic myocardium. Circulation 1985; 71: 1038-1047.
42. Trevi GP, Sheiban I. Chronic ischaemic ('hibernating') and postischaemic ('stunned') dysfunctional but viable myocardium. Eur Heart J 1991; 12(Suppl.G): 20-26.